SCHEMBL9708139

SCHEMBL9708139

COC(=O)Cn1c(=O)n(C)c(=O)c2c1nc(CC(C)(C)C)n2Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.42
TP53 P04637 2/20 0.42
AGTR1 P30556 5/20 0.42
AGTR2 P50052 5/20 0.42
ALDH1A1 P00352 4/20 0.40
GAA P10253 1/20 0.40
ALOX15 P16050 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 2/20 0.39
LMNA P02545 2/20 0.39
MEN1 O00255 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 2/20 0.38
PPARG P37231 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9707449 0.94 KMT2A (0.45) TSHRTP53AGTR1AGTR2ALDH1A1
SCHEMBL9707900 0.94 AGTR1 (0.43) TSHRTP53AGTR1AGTR2MEN1
SCHEMBL9707642 0.92 AGTR1 (0.43) AGTR1AGTR2KMT2APPARG
SCHEMBL9707542 0.92 AGTR1 (0.43) AGTR1AGTR2KMT2APPARG
SCHEMBL9708279 0.92 AGTR1 (0.45) TSHRTP53AGTR1AGTR2ALDH1A1
SCHEMBL9708964 0.92 AGTR1 (0.40) TSHRTP53AGTR1AGTR2ALDH1A1
SCHEMBL9708108 0.91 AGTR1 (0.44) TSHRAGTR1AGTR2MEN1CYP2C9
SCHEMBL9708693 0.91 AGTR1 (0.41) TSHRAGTR1AGTR2ALDH1A1GAA
SCHEMBL9707550 0.91 AGTR1 (0.40) TSHRAGTR1AGTR2ALDH1A1GAA
SCHEMBL9707639 0.91 AGTR1 (0.40) TSHRTP53AGTR1AGTR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed